Arax Advisory Partners
HAE icon

Arax Advisory Partners’s Haemonetics HAE Stock Holding History

Arax Advisory Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.34M Buy
12,724
+1,008
+9% +$93.8K 0.01% 1188
2026
Q2 		$879K Buy
11,716
+11,583
+8,709% +$744K 0.01% 1295
2026
Q1 		$7.5K Sell
133
-127
-49% -$8.27K ﹤0.01% 2598
2025
Q4 		$20.8K Sell
260
-10,153
-98% -$682K ﹤0.01% 2088
2025
Q3 		$508K Buy
10,413
+9,789
+1,569% +$606K 0.01% 895
2025
Q2 		$46.6K Buy
624
+609
+4,060% +$40.3K ﹤0.01% 1274
2025
Q1 		$954 Buy
15
+6
+67% +$408 ﹤0.01% 2316
2024
Q4 		$703 Sell
9
-30
-77% -$2.41K ﹤0.01% 2248
2024
Q3 		$3.14K Hold
39
– – ﹤0.01% 1905
2024
Q2 		$3.23K Buy
+39
New +$3.43K ﹤0.01% 1793
2023
Q4 		– Sell
-7
Closed -$628 – 1377
2023
Q3 		$628 Sell
7
-13
-65% -$1.16K ﹤0.01% 1214
2023
Q2 		$1.7K Sell
20
-18
-47% -$1.52K ﹤0.01% 1028
2023
Q1 		$3.14K Buy
38
+25
+192% +$2.02K ﹤0.01% 942
2022
Q4 		$1.02K Hold
13
– – ﹤0.01% 1067
2022
Q3 		$1K Buy
+13
New +$933 ﹤0.01% 1081

Other funds holding HAE

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Ariel Investments
Ariel Investments Chicago, Illinois $9.6B AUM 22.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
River Road Asset Management
River Road Asset Management Louisville, Kentucky $8.42B AUM 5.65% 1-Year Est. Return

Arax Advisory Partners's HAE Position: Q3 2026 in Review

Arax Advisory Partners increased its Haemonetics (HAE) stake by 8.6% in Q3 2026, buying an estimated $93.8K and bringing the position to 12,724 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #1188.

Arax Advisory Partners first reported a position in HAE in Q3 2022 and has held it in 15 quarters since. 269 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • Arax Advisory Partners held 12,724 shares of Haemonetics worth $1.34M as of Q3 2026.
  • Arax Advisory Partners bought 1,008 Haemonetics shares in Q3 2026, an estimated $93.8K.
  • Haemonetics made up 0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #1188 holding.
  • Arax Advisory Partners first reported a position in Haemonetics in Q3 2022 and has held it in 15 quarters since.
  • 269 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.